Spots Global Cancer Trial Database for bmi
Every month we try and update this database with for bmi cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Breast Cancer, Breast Disease, and Pesticides | NCT00341315 | Breast Cancer | 35 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients | NCT01020604 | Prostate Cancer Obesity | 18 Years - | AstraZeneca | ||
Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients | NCT03873064 | Neoplasm Malign... Body Weight Quality of Life | 18 Years - | University of Rome Tor Vergata | ||
Breast Cancer, Breast Disease, and Pesticides | NCT00341315 | Breast Cancer | 35 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS) | NCT02328404 | Polycystic Ovar... Hypovitaminosis... | 50,000 IU vitam... Placebo | 18 Years - 49 Years | Hayat Pharmaceutical Co. PLC | |
Exemestane-RAD001-Metformin | NCT01627067 | Breast Cancer | Everolimus Exemestane Metformin | 18 Years - | M.D. Anderson Cancer Center | |
Role of Serum Albumin and Total Protein in Survival of Cancer Cachectic Patients | NCT05103059 | Cancer | BMI | 18 Years - | Assiut University | |
Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer | NCT01542203 | Breast Cancer | 18 Years - | University of Texas Southwestern Medical Center | ||
A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and Tamoxifen | NCT01223833 | Breast Cancer Arthralgia | 18 Years - | Universitaire Ziekenhuizen KU Leuven | ||
Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer | NCT00463489 | Breast Cancer | Lifestyle inter... Mail-based | - | Ontario Clinical Oncology Group (OCOG) | |
Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer | NCT01542203 | Breast Cancer | 18 Years - | University of Texas Southwestern Medical Center | ||
The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer | NCT01643148 | Female Breast C... | 40 Years - 60 Years | Materno-Perinatal Hospital of the State of Mexico | ||
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS) | NCT02328404 | Polycystic Ovar... Hypovitaminosis... | 50,000 IU vitam... Placebo | 18 Years - 49 Years | Hayat Pharmaceutical Co. PLC | |
Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory | NCT01157130 | Early Stage Bre... | Exercise Regime... | 18 Years - | Nevada Cancer Institute | |
PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients | NCT01020604 | Prostate Cancer Obesity | 18 Years - | AstraZeneca | ||
Natural History of NFAI: 10 Year Follow-up Results | NCT04616703 | Adrenal Inciden... | CT imaging | 18 Years - | University Medical Centre Ljubljana | |
Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer | NCT03286920 | Esophageal Canc... | Oral nutrition ... Tube feeding nu... | - 80 Years | Peking University Cancer Hospital & Institute | |
Water Method in Low-body Mass Index (BMI) Female Patients With Unsedated Colonoscopy | NCT01546259 | Adenoma Pain | Water colonosco... | 18 Years - 80 Years | Air Force Military Medical University, China | |
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS) | NCT02328404 | Polycystic Ovar... Hypovitaminosis... | 50,000 IU vitam... Placebo | 18 Years - 49 Years | Hayat Pharmaceutical Co. PLC | |
Natural History of NFAI: 10 Year Follow-up Results | NCT04616703 | Adrenal Inciden... | CT imaging | 18 Years - | University Medical Centre Ljubljana | |
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas | NCT00495235 | Endometrial Can... | Questionnaire | - | M.D. Anderson Cancer Center | |
A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and Tamoxifen | NCT01223833 | Breast Cancer Arthralgia | 18 Years - | Universitaire Ziekenhuizen KU Leuven | ||
PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients | NCT01020604 | Prostate Cancer Obesity | 18 Years - | AstraZeneca | ||
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS) | NCT02328404 | Polycystic Ovar... Hypovitaminosis... | 50,000 IU vitam... Placebo | 18 Years - 49 Years | Hayat Pharmaceutical Co. PLC | |
Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer | NCT00463489 | Breast Cancer | Lifestyle inter... Mail-based | - | Ontario Clinical Oncology Group (OCOG) |